Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk considerations related to lung modeling.

R Masse1, F T Cross

  • 1CEA, Institut de Protection et de Sûreté Nucléaire, DPS/SPE, Centre d'Etudes de Fontenay aux Roses, France.

Health Physics
|January 1, 1989
PubMed
Summary

Improved lung models enhance radiation dose assessment for inhalation exposures. Current models propose attributing 80% of respiratory tract cancer risk to the lung, with specific partitions for different lung regions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The causes of cancer in France.

Annals of oncology : official journal of the European Society for Medical Oncology·2008
Same author

Opinions of Quebec parents and vaccinators on the usefulness of chickenpox vaccine.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2007
Same author

Low-dose risk assessment.

Radiation research·2007
Same author

The debate on the use of linear no threshold for assessing the effects of low doses.

Journal of radiological protection : official journal of the Society for Radiological Protection·2006
Same author

Recent reports on the effect of low doses of ionizing radiation and its dose-effect relationship.

Radiation and environmental biophysics·2006
Same author

Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone.

Xenobiotica; the fate of foreign compounds in biological systems·2005

Area of Science:

  • Radiation dosimetry and risk assessment
  • Pulmonary oncology and carcinogenesis
  • Inhalation exposure and lung modeling

Background:

  • Accurate lung models are crucial for assessing inhalation exposure doses and establishing reliable dose-response relationships for risk evaluation and exposure limits.
  • Epidemiological data reveal varying excess respiratory tract carcinoma rates in different lung regions, but precise histogenesis, location, and progenitor cells remain unclear for microdosimetry.
  • Basal cells in stratified epithelia are considered the primary cells at risk for radiation-induced cancer in the respiratory tract.

Purpose of the Study:

  • To refine lung models for more accurate dose assessment in inhalation exposures.
  • To evaluate the distribution of cancer risk within the respiratory tract, specifically between upper airways and the lung.
  • To inform risk weighting factor allocation based on epidemiological data and lung model characteristics.

Related Experiment Videos

Main Methods:

  • Utilized epidemiological data from irradiated individuals (therapeutic and atomic bomb survivors) to observe tumor distribution.
  • Incorporated findings from animal studies (rats) on lung cancer induction by different alpha-emitters.
  • Applied the International Commission on Radiological Protection (ICRP) Lung-Model Task Group's proposed risk partitioning framework.

Main Results:

  • The ICRP Lung-Model Task Group proposes allocating 80% of the total respiratory tract cancer risk to the lung, with specific partitions for different lung regions (e.g., 64% for generations 0-16, 16% for generations 17-23).
  • Animal studies indicate lower lung cancer induction effectiveness from insoluble long-lived alpha-emitters compared to radon daughters at low doses, potentially due to regional irradiation differences.
  • Lymph node tumors are rare, leading to a suggested maximum risk of 1/100th of the total respiratory tract risk for lymphatic tissue.

Conclusions:

  • Improved lung models are essential for accurate dose assessment and risk evaluation following inhalation exposures.
  • A significant majority of the respiratory tract cancer risk is proposed to be attributed to the lung, with specific regional distributions.
  • Further research is needed to clarify cell-of-origin and microdosimetry for precise risk assessment in different respiratory tract compartments.